GEFISTERIS 250 is a prescription anti-cancer medicine that contains Gefitinib 250 mg. It belongs to a group of medicines known as EGFR tyrosine kinase inhibitors (TKIs), which are mainly used in the treatment of non-small cell lung cancer (NSCLC).

In simple words, gefitinib 250 mg tablet works by blocking a specific protein (EGFR) that helps cancer cells grow and multiply. By stopping this signal, the medicine slows down cancer growth and may even shrink tumors in some patients.In India, lung cancer cases are increasing due to smoking, pollution, and lifestyle factors. That’s why gefitinib 250 mg uses are very important in modern cancer therapy, especially for patients with EGFR-positive mutations.

GEFISTERIS 250 is usually prescribed by oncologists after proper testing and diagnosis. It is not a general painkiller or antibiotic—it is a targeted cancer therapy.

Uses of Gefitinib 250 mg

The main gefitinib 250 mg uses are related to lung cancer treatment and targeted therapy.

1. Non-Small Cell Lung Cancer (NSCLC)

The primary use of tab gefitinib 250 mg is in treating advanced or metastatic NSCLC, especially EGFR mutation-positive cases.

2. EGFR Mutation-Positive Cancer

Gefitinib 250 mg tablet works best in patients whose cancer cells have EGFR gene mutations.

3. Second-Line or First-Line Therapy

Doctors may prescribe gefitinib 250 mg either as first treatment or after chemotherapy, depending on patient condition.

4. Cancer Progression Control

It helps slow down the spread of cancer cells in the lungs and other parts of the body.

5. Symptom Management

Gefitinib 250 mg uses also include improving breathing difficulty, cough, and chest discomfort in lung cancer patients.

Benefits of GEFISTERIS 250

GEFISTERIS 250 offers important benefits in targeted cancer treatment:

Targets Cancer Cells Directly

Unlike chemotherapy, gefitinib 250 mg tablet specifically blocks cancer growth signals.

Slows Tumor Growth

It helps reduce or control tumor progression in lung cancer patients.

Improves Quality of Life

Patients may experience better breathing, less cough, and improved daily comfort.

Oral Treatment Option

Gefitinib 250 mg tablet is taken orally, making it more convenient than hospital-based chemotherapy.

Better Tolerability

Many patients tolerate gefitinib 250 mg uses better compared to traditional chemotherapy drugs.

Dosage of Gefitinib 250 mg

The gefitinib 250 mg dose should always be taken exactly as prescribed by an oncologist.

General Guidelines:

• Usual dose: 1 tablet (250 mg) once daily
• Take tab gefitinib 250 mg at the same time every day
• Can be taken with or without food
• Swallow whole with water

Important Instructions:

• Do not crush or split gefitinib 250 mg tablet
• Continue treatment as long as your doctor advises
• Regular check-ups and scans are required

Missed Dose:

If you miss a dose of gefitinib 250 mg, take it as soon as you remember. If it is close to the next dose, skip it. Do not double dose.

Side Effects of Gefitinib 250 mg

Like all cancer medicines, gefitinib 250 mg side effects may occur, and patients should be aware of them.

Common Side Effects:

• Diarrhea
• Skin rash or acne-like breakouts
• Dry skin
• Loss of appetite
• Weakness
• Mouth sores

Serious Side Effects:

• Breathing problems
• Severe lung inflammation (rare but serious)
• Liver function changes
• Severe diarrhea or dehydration

If any serious gefitinib 250 mg side effects occur, contact your doctor immediately.

Warnings and Precautions

Before using GEFISTERIS 250, follow these important safety points:

Prescription Only Medicine

Gefitinib 250 mg tablet must only be taken under oncologist supervision.

EGFR Testing Required

This medicine works best only in EGFR-positive lung cancer patients.

Liver Monitoring

Regular liver function tests are needed during gefitinib 250 mg uses.

Lung Symptoms

Report any sudden breathing issues immediately, as it may indicate lung inflammation.

Pregnancy & Breastfeeding

Not recommended during pregnancy or breastfeeding.

Drug Interactions

Inform your doctor if you are taking:

• Acid reducers
• Antibiotics
• Antifungal medicines

These may affect gefitinib 250 mg dose effectiveness.

About Steris Healthcare

Steris Healthcare is a trusted pharmaceutical company in India known for delivering high-quality and affordable medicines across multiple therapeutic areas. The company focuses on oncology, chronic care, and critical care segments.

With strong quality standards and advanced manufacturing practices, Steris Healthcare ensures that medicines like GEFISTERIS 250 meet global safety and effectiveness requirements, helping improve patient outcomes in serious conditions like cancer.

Frequently Asked Questions (FAQs)

Q1. What is GEFISTERIS 250 used for?

It is used to treat EGFR-positive non-small cell lung cancer.

Q2. What are the main gefitinib 250 mg uses?

It is mainly used for lung cancer treatment and controlling tumor growth.

Q3. How should I take gefitinib 250 mg tablet?

Take one tablet daily as prescribed by your doctor, with or without food.

Q4. What are common gefitinib 250 mg side effects?

Common side effects include rash, diarrhea, and weakness.

Q5. Is gefitinib 250 mg a chemotherapy drug?

No, it is a targeted therapy drug, not traditional chemotherapy.

Conclusion

GEFISTERIS 250 (Gefitinib 250 mg) is an advanced targeted therapy used in the treatment of EGFR-positive non-small cell lung cancer. It works by blocking cancer cell growth signals and helping slow disease progression.

When used correctly, gefitinib 250 mg tablet can improve symptoms, enhance quality of life, and provide better treatment outcomes for lung cancer patients.However, gefitinib 250 mg uses must always be guided by a qualified oncologist with regular monitoring and follow-up tests. Self-medication is strictly not recommended.